探索喘作为COVID-19结果中的保护因素
Anthony E Quinn1, Lei Zhao2, Scott D Bell1
1Department of Microbiology, Immunology & Pathology, College of Osteopathic Medicine, Des Moines University, West Des Moines, IA 50266, USA.
International journal of molecular sciences
|February 26, 2025
概括
感染SARS-CoV-2的喘患者表现更好,疾病严重程度和住院率较低. 这篇综述探讨了诸如乙酸和喘中降低的ACE-2表达等保护机制,这可能解释了这些发现.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 病毒学 病毒学
背景情况:
- 喘通常与病毒性呼吸道感染的更糟糕结果有关.
- 然而,COVID-19 (由SARS-CoV-2引起) 在喘患者中呈现出截然不同的模式,显示疾病严重程度和死亡率降低.
研究的目的:
- 审查喘中潜在的保护性免疫和生理机制,这可能解释SARS-CoV-2感染期间的有利结果.
- 突出可能在病毒性呼吸道流行病背景下告知喘管理的因素.
主要方法:
- 文献综述和综合有关喘,病毒感染和COVID-19的现有研究.
- 免疫反应 (乙素,Th2反应) 和生理因素 (ACE-2表达,吸入皮质类固醇) 的分析.
主要成果:
- 喘患者的严重COVID-19病例,住院治疗,发病率和死亡率较低.
- 潜在的保护因素包括增强抗病毒防御的eosinophilia,控制炎症的吸入性皮质类固醇,减少限制病毒进入的ACE-2表达,以及抵消在关键COVID-19中看到的严重Th1反应的主导Th2免疫反应.
结论:
- 喘的特定特征,如阴,皮质类固醇使用,降低ACE-2表达和Th2-主导免疫力,可能会对严重的COVID-19产生保护.
- 了解这些机制对于在病毒性呼吸道爆发期间管理喘患者至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
326
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
326
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
226
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
226
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


